Medical device manufacturers making cosmetic / aesthetic products.
GC Aesthetics says it raised $60 million from a trio of healthcare investors.
GC Aesthetics brought $60 million from 3 healthcare investment groups it plans to use to expand its breast implant business.
Dublin-based GC Aesthetics is the umbrella company for 2 different brands, Nagor and Eurosilicone.The funding round was led by a $40 million contribution from OrbiMed, with existing backers Montreux Equity Partners and Oyster Capital contributing the rest.
Syneron Medical has a big week with Q4 earnings that beat estimates, a new chief executive and the $15 million acquisition of New Star Lasers and its CoolTouch aesthetic devices.
Israeli device maker Syneron Medical Ltd. (NSDQ:ELOS) made some major moves this month, announcing a new CEO alongside strong Q4 earnings and signing a deal to acquire New Lasers Inc.
Miramar Labs reels in a $10 million Series D round it plans to use to boost sales of its miraDry excessive sweat treatment.
Miramar Labs said it landed a $10 million Series D round it plans to use to boost sales of its miraDry system.
Sunnyvale, Calif.-based Miramar makes dermatology devices including its flagship miraDry system, a laser-based treatment for excessive underarm sweat. The device, which uses microwave energy to eliminate sweat glands, recently won CE Mark approval in the European Union.
DEKA Medical secures 510(k) clearance from the FDA for its Synchro REPLA:Y laser, available for a variety of cosmetic treatments.
DEKA Medical won 510(k) clearance from the FDA for its Synchro REPLA:Y laser. The device is indicated for the treatment of a variety of aesthetic treatments.
Kinetic Concepts announces the acquisition by sister company LifeCell Corp. of fat-grafting adipose Tissue Injector technology from TauTona Group.
Kinetic Concepts sister company LifeCell this week announced the acquisition of fat-injection devices from California medtech group TauTona.
LifeCell hopes to use the deal, the details of which were not disclosed, to expand its reconstructive and cosmetic portfolio with the fat grafting technology.
Valeant Pharmaceuticals consummates its $250 million acquisition of aesthetics maker Solta Medical after completing a tender offer of $2.92 per share for its new subsidiary.
Cynosure wins approval for its tattoo removal technology in South Korea and Taiwan.
Cynosure (NSDQ:CYNO) said it won marketing approval for its PicoSure laser in South Korea and Taiwan.